Madalyn Neff

About Madalyn Neff

This author has not yet filled in any details.
So far Madalyn Neff has created 56 blog entries.

[Blog Post] Tackling the Costs that Can Impede Expanded Access

A blog post by Clinical Research Pathways Executive Director Marjorie A. Speers, Ph.D.

A streamlined Food and Drug Administration (FDA) expanded access process has made it easier for desperately ill patients to try experimental drugs, biologics, and medical devices. Despite this progress, costs—to patients, healthcare providers, and product developers—present significant barriers to participation.

As a result, […]

2020-02-03T16:35:17-05:00February 3, 2020|General|

[Blog Post] Transparency Informs Diversity Efforts

In response to increased public interest, the Food and Drug Administration (FDA) provides data on the demographic makeup of clinical trials for recently approved drugs. In 2018, for example, FDA approved 59 new drugs based on the results of clinical trials involving nearly 44,000 participants. Of those, 69% were white and 56% were women. In […]

2020-06-23T17:24:05-04:00January 20, 2020|General|

[Blog Post] Tackling One of the Most Preventable Cancers

January is Cervical Health Awareness Month, an ideal time to call attention to one of the most preventable cancers.

The good news is that cervical cancer rates have declined significantly because of widespread use of the Pap screening test. Even better, cervical cancer can now be prevented by a vaccine that targets HPV, the virus that […]

2020-06-23T17:23:38-04:00January 6, 2020|General|

[News Release] Clinical Research Pathways Partners with WellStar Health System to Increase Diversity in Clinical Trials

Grant to promote minority participation in cancer research

ATLANTA, December 12, 2019—Clinical Research Pathways is partnering with WellStar Health System to increase diversity in oncology research to help ensure that new cancer medicines are effective for patients of all races and ethnicities.

The two organizations—a nonprofit focused on creating pathways to new medicines and treatments, and one […]

2019-12-12T09:21:29-05:00December 12, 2019|News|

[Blog Post] How Diversity Achieves Health Equity

This #GivingTuesday, help us advance health equity

Everyone should benefit from clinical trials. But because some racial and ethnic groups are underrepresented in clinical research, they might benefit less.

Most of today’s medicines and other therapies are based on data obtained primarily from white clinical trial […]

2019-12-02T13:00:06-05:00December 2, 2019|General|

Let’s make new medicines work for everyone

Almost every medicine you take has been tested beforehand in a clinical trial. But if you’re not white or male, there’s a good chance people like you were not included in the trial group—so the trial results might not apply. Maybe a different dose or a different medicine would be more effective.

We can’t be confident […]

2019-11-18T17:02:32-05:00November 18, 2019|General|

[Blog Post] Lung Cancer Takes Higher Toll on Black Americans

Lung cancer is the most common cancer worldwide and the leading cause of cancer deaths among U.S. men and women. The news is even worse for black Americans, who are more likely than any other racial or ethnic group to get—and die from—lung cancer.

November is Lung Cancer Awareness Month, a time to call attention to […]

2019-11-04T16:43:34-05:00November 4, 2019|General|
Load More Posts